204 related articles for article (PubMed ID: 226307)
21. [Familial hyperlipoproteinemia type III].
Patsch JR; Patsch W; Sailer S; Braunsteiner H
Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039
[No Abstract] [Full Text] [Related]
22. [Clinical experimentation of clofibride. Apropos of 40 cases].
Warembourg H; Jaillard J
Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
[No Abstract] [Full Text] [Related]
23. [Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)].
Wilke H; Frahm H
Dtsch Med Wochenschr; 1976 Mar; 101(11):401-5. PubMed ID: 1253701
[TBL] [Abstract][Full Text] [Related]
24. [New drug combination for medical management of hyperlipemia: clinical study].
Fischer M; Falkensammer C
Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):585-9. PubMed ID: 340391
[TBL] [Abstract][Full Text] [Related]
25. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
26. Gemfibrozil treatment: a comparison with clofibrate.
Howard AN; Ghosh P
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
[TBL] [Abstract][Full Text] [Related]
27. [Clinical and therapeutic evaluation of a new antilipemic substance].
de Aguiar Magano L
Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
[TBL] [Abstract][Full Text] [Related]
28. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
Proto C; Quadri A; Ratti S; Levi GF; Prandini BD
G Ital Cardiol; 1978; 8(7):743-51. PubMed ID: 355033
[TBL] [Abstract][Full Text] [Related]
29. [Drug therapy of hyperlipidemias].
Wolfram G
Wien Med Wochenschr; 1981; 131(13-14):333-8. PubMed ID: 7281700
[No Abstract] [Full Text] [Related]
30. [Effect of tibric acid (CP-18.254) on plasma lipids in patients with primary endogenous hyperlipoproteinemia].
Lisch HJ; Sailer S; Braunsteiner H
Arzneimittelforschung; 1977; 27(10):2017-20. PubMed ID: 579116
[TBL] [Abstract][Full Text] [Related]
31. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
Maroto ML; Priego JG; Piña M; Catalán RE
Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
[No Abstract] [Full Text] [Related]
32. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Orö L; Olsson AG; Rössner S; Carlson LA
Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
[TBL] [Abstract][Full Text] [Related]
33. Does hypolipidemic therapy prevent coronary heart disease?
Rifkind BM; Levy RI
Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
[No Abstract] [Full Text] [Related]
34. [The when and how of therapy for hyperlipoproteinemia].
Mordasini R
Schweiz Med Wochenschr; 1978 Jan; 108(4):113-9. PubMed ID: 203028
[TBL] [Abstract][Full Text] [Related]
35. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Orö L; Olsson AG; Rössner S; Carlson LA
Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639
[No Abstract] [Full Text] [Related]
36. The primary hyperlipoproteinemias.
Bybee DE; Hamilton RD
J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
[No Abstract] [Full Text] [Related]
37. The effect of pirozadil on plasma lipids and lipoproteins in 1185 hyperlipidaemic subjects. Multicentre study in general practice in Spain.
Tapounet R; Marti Ragué I
Drugs Exp Clin Res; 1987; 13(7):447-50. PubMed ID: 3652931
[TBL] [Abstract][Full Text] [Related]
38. Dose-response effect of single and combined clofibrate (Atromidin) and niceritrol (Perycit) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia.
Olsson AG; Orö L; Rössner S
Atherosclerosis; 1975; 22(1):91-101. PubMed ID: 1098680
[TBL] [Abstract][Full Text] [Related]
39. Serum lipoprotein lipids after gemfibrozil treatment.
Schwandt P; Weisweiler P; Neureuther G
Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
[TBL] [Abstract][Full Text] [Related]
40. [Correction of hyperdyslipidemia using polyene-structure substances. Controlled clinical trial].
Pagliano FM
Arch Sci Med (Torino); 1979; 136(2):303-8. PubMed ID: 391176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
